<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT02480673</url>
  </required_header>
  <id_info>
    <org_study_id>R-2015-785-047</org_study_id>
    <nct_id>NCT02480673</nct_id>
  </id_info>
  <brief_title>EFFECT OF Salvia Hispanica l. (CHIA) IN THE BIOCHEMICAL METABOLIC SYNDROME COMPONENTS</brief_title>
  <official_title>EFFECT OF Salvia Hispanica L. ( CHIA ) IN THE BIOCHEMICAL METABOLIC SYNDROME COMPONENTS IN PATIENTS IN THE NATIONAL MEDICAL CENTER WEST OF THE MEXICAN SOCIAL SECURITY INSTITUTE</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Instituto Mexicano del Seguro Social</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Instituto Mexicano del Seguro Social</source>
  <oversight_info>
    <has_dmc>Yes</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      The objective of this study is to evaluate the effect of the administration of 25 g of chia
      per day, for 90 days on the biochemical components of the metabolic syndrome in subjects with
      this condition
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      The metabolic syndrome (MS) is a cardiovascular risk factor and is present in about 20-25% of
      the world's adult population. Individuals with this condition have twice the risk of
      cardiovascular disease and die from it, compared with those who do not and 5 times more
      likely to develop type 2 diabetes mellitus (DM2). For this reason, it is appropriate to
      develop better tools for prevention and management of MS, with more emphasis on lifestyle´s
      changes. Chia has been studied in the past 10 years due to its high concentration of omega-3
      alpha-linolenic acid (ALA) and 6 linoleic acid (LA) showing beneficial effects in some
      components of MS in rodents and individuals. The addition of chia to the conventional
      treatment of MS for the modification of metabolic disorders provides us a tool for easy
      incorporation into daily life, inexpensive and accessible in our environment.
    </textblock>
  </detailed_description>
  <overall_status>Unknown status</overall_status>
  <last_known_status>Recruiting</last_known_status>
  <start_date>June 2015</start_date>
  <completion_date type="Anticipated">May 2016</completion_date>
  <primary_completion_date type="Anticipated">December 2015</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Supportive Care</primary_purpose>
    <masking>None (Open Label)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Change in serum glucose levels</measure>
    <time_frame>94 days (plus or minus 4 days)</time_frame>
    <description>Fasting, postprandial and post challenge oral test glucose and HbA1c</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Variation in lipid profile</measure>
    <time_frame>94 days (plus or minus 4 days)</time_frame>
    <description>Triglycerides, HDL-cholesterol, LDL-cholesterol and total cholesterol</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Modification in insulin resistance</measure>
    <time_frame>94 days (plus or minus 4 days)</time_frame>
    <description>Serum insulin, homeostasis model assessment index</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Change in systolic blood pressure</measure>
    <time_frame>94 days (plus or minus 4 days)</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Change in diastolic blood pressure</measure>
    <time_frame>94 days (plus or minus 4 days)</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Variation in body weight</measure>
    <time_frame>94 days (plus or minus 4 days)</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Modification in waist circumference</measure>
    <time_frame>94 days (plus or minus 4 days)</time_frame>
  </secondary_outcome>
  <number_of_arms>4</number_of_arms>
  <enrollment type="Anticipated">100</enrollment>
  <condition>Metabolic Syndrome X</condition>
  <arm_group>
    <arm_group_label>Free diet plus Chia</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>This subjects will consume 1 cookie oatmeal with chia before breakfast and dinner for 90 days without changing their diet</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Normocaloric diet plus chia</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>This subjects will consume 1 cookie oatmeal with chia before breakfast and dinner for 90 days along with a normocaloric diet</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Normocaloric diet plus oatmeal</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>This subjects will consume 1 cookie oatmeal before breakfast and dinner for 90 days along with a normocaloric diet</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Normocaloric diet</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>This subjects will only go under a normocaloric diet for 90 days</description>
  </arm_group>
  <intervention>
    <intervention_type>Dietary Supplement</intervention_type>
    <intervention_name>Chia</intervention_name>
    <description>The subject will eat 25 gr of chia in 2 oatmeal cookies at day</description>
    <arm_group_label>Free diet plus Chia</arm_group_label>
    <arm_group_label>Normocaloric diet plus chia</arm_group_label>
    <other_name>Salvia hispanica</other_name>
  </intervention>
  <intervention>
    <intervention_type>Dietary Supplement</intervention_type>
    <intervention_name>Oatmeal</intervention_name>
    <description>The subject will eat 2 oatmeal cookies a day containing the exactly same quantity of oats in the oatmeal cookies with chia.</description>
    <arm_group_label>Normocaloric diet plus oatmeal</arm_group_label>
    <other_name>Oats</other_name>
  </intervention>
  <intervention>
    <intervention_type>Behavioral</intervention_type>
    <intervention_name>Normocaloric diet</intervention_name>
    <description>The healthy diet plan distribution will be 50% carbohydrate, 25 % protein, 35 % fat to less than 7 % saturated fat and less than 200 mg/d cholesterol and 20-30 g of fiber.</description>
    <arm_group_label>Normocaloric diet plus chia</arm_group_label>
    <arm_group_label>Normocaloric diet plus oatmeal</arm_group_label>
    <arm_group_label>Normocaloric diet</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Diagnosis of metabolic syndrome according to Adult Treatment Panel - III criteria.

          -  Subject wishing to participate in the study by written consent.

          -  Instituto Mexicano del Seguro Social beneficiaries subject

          -  Subject who not requiring modification of medical treatment for MS in the recruitment
             period.

        Exclusion Criteria:

          -  Chronic renal failure with filtration glomerular rate clearance less than 30ml / min.

          -  Diabetic neuropathy.

          -  Post menopause

          -  Intestinal malabsorption diseases .

          -  Type 2 diabetes with HbA1c &gt; 8.5 %

          -  Systolic and diastolic blood pressure &gt;140/90 mmHg.

          -  Triglycerides &gt; 300 mg/dL.

          -  LDL cholesterol &gt;160mg/dL.

          -  Systemic autoimmune diseases .

          -  Cirrhosis or liver failure .

          -  Subject infected with human immunodeficiency virus or acquired immunodeficiency
             syndrome .

          -  Diagnosis of cancer with active disease.

          -  Subject previously undergoing bariatric surgery.

          -  Pregnancy or lactation.

          -  Alcoholism and drug addiction.

          -  Subject who consume high fiber dietary supplements and / or omega 3 acids.

          -  Subject taking anorexic drugs.

          -  Subject under diet for weight loss implemented by a health professional.
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>50 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Ana E Perez Verdin, MD</last_name>
    <role>Principal Investigator</role>
  </overall_official>
  <overall_contact>
    <last_name>Ana E Perez Verdin, MD</last_name>
    <phone>011523336170060</phone>
    <phone_ext>31465</phone_ext>
    <email>verdinmd@hotmail.com</email>
  </overall_contact>
  <overall_contact_backup>
    <last_name>Blanca M Torres Mendoza, PhD</last_name>
    <phone>011523336170060</phone>
    <phone_ext>31950</phone_ext>
    <email>bltorres1@hotmail.com</email>
  </overall_contact_backup>
  <location>
    <facility>
      <name>Instituto Mexicano Del Seguro Social Hospital de Especialidades, Centro Medico Nacional de Occidente Lic. Ignacio Garcia Tellez Unidad Medica de Alta Especialidad</name>
      <address>
        <city>Guadalajara</city>
        <state>Jalisco</state>
        <zip>44340</zip>
        <country>Mexico</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Ana E Pérez Verdin, MD</last_name>
      <phone>011523336170060</phone>
      <phone_ext>31465</phone_ext>
      <email>verdinmd@hotmail.com</email>
    </contact>
    <contact_backup>
      <last_name>Blanca M Torres Mendoza, PhD</last_name>
      <phone>011523336170060</phone>
      <phone_ext>31950</phone_ext>
      <email>bltorres1@hotmail.com</email>
    </contact_backup>
  </location>
  <location_countries>
    <country>Mexico</country>
  </location_countries>
  <results_reference>
    <citation>Mohd Ali N, Yeap SK, Ho WY, Beh BK, Tan SW, Tan SG. The promising future of chia, Salvia hispanica L. J Biomed Biotechnol. 2012;2012:171956. doi: 10.1155/2012/171956. Epub 2012 Nov 21. Review.</citation>
    <PMID>23251075</PMID>
  </results_reference>
  <results_reference>
    <citation>Ayerza R Jr, Coates W. Effect of dietary alpha-linolenic fatty acid derived from chia when fed as ground seed, whole seed and oil on lipid content and fatty acid composition of rat plasma. Ann Nutr Metab. 2007;51(1):27-34. Epub 2007 Mar 14.</citation>
    <PMID>17356263</PMID>
  </results_reference>
  <results_reference>
    <citation>Chicco AG, D'Alessandro ME, Hein GJ, Oliva ME, Lombardo YB. Dietary chia seed (Salvia hispanica L.) rich in alpha-linolenic acid improves adiposity and normalises hypertriacylglycerolaemia and insulin resistance in dyslipaemic rats. Br J Nutr. 2009 Jan;101(1):41-50. doi: 10.1017/S000711450899053X. Epub 2008 May 20.</citation>
    <PMID>18492301</PMID>
  </results_reference>
  <results_reference>
    <citation>Rossi AS, Oliva ME, Ferreira MR, Chicco A, Lombardo YB. Dietary chia seed induced changes in hepatic transcription factors and their target lipogenic and oxidative enzyme activities in dyslipidaemic insulin-resistant rats. Br J Nutr. 2013 May;109(9):1617-27. doi: 10.1017/S0007114512003558. Epub 2012 Sep 5.</citation>
    <PMID>22947172</PMID>
  </results_reference>
  <results_reference>
    <citation>Oliva ME, Ferreira MR, Chicco A, Lombardo YB. Dietary Salba (Salvia hispanica L) seed rich in α-linolenic acid improves adipose tissue dysfunction and the altered skeletal muscle glucose and lipid metabolism in dyslipidemic insulin-resistant rats. Prostaglandins Leukot Essent Fatty Acids. 2013 Oct;89(5):279-89. doi: 10.1016/j.plefa.2013.09.010. Epub 2013 Sep 25.</citation>
    <PMID>24120122</PMID>
  </results_reference>
  <results_reference>
    <citation>Poudyal H, Panchal SK, Waanders J, Ward L, Brown L. Lipid redistribution by α-linolenic acid-rich chia seed inhibits stearoyl-CoA desaturase-1 and induces cardiac and hepatic protection in diet-induced obese rats. J Nutr Biochem. 2012 Feb;23(2):153-62. doi: 10.1016/j.jnutbio.2010.11.011. Epub 2011 Mar 22.</citation>
    <PMID>21429727</PMID>
  </results_reference>
  <results_reference>
    <citation>Vuksan V, Whitham D, Sievenpiper JL, Jenkins AL, Rogovik AL, Bazinet RP, Vidgen E, Hanna A. Supplementation of conventional therapy with the novel grain Salba (Salvia hispanica L.) improves major and emerging cardiovascular risk factors in type 2 diabetes: results of a randomized controlled trial. Diabetes Care. 2007 Nov;30(11):2804-10. Epub 2007 Aug 8.</citation>
    <PMID>17686832</PMID>
  </results_reference>
  <results_reference>
    <citation>Nieman DC, Cayea EJ, Austin MD, Henson DA, McAnulty SR, Jin F. Chia seed does not promote weight loss or alter disease risk factors in overweight adults. Nutr Res. 2009 Jun;29(6):414-8. doi: 10.1016/j.nutres.2009.05.011.</citation>
    <PMID>19628108</PMID>
  </results_reference>
  <results_reference>
    <citation>Jin F, Nieman DC, Sha W, Xie G, Qiu Y, Jia W. Supplementation of milled chia seeds increases plasma ALA and EPA in postmenopausal women. Plant Foods Hum Nutr. 2012 Jun;67(2):105-10. doi: 10.1007/s11130-012-0286-0.</citation>
    <PMID>22538527</PMID>
  </results_reference>
  <results_reference>
    <citation>Vuksan V, Jenkins AL, Dias AG, Lee AS, Jovanovski E, Rogovik AL, Hanna A. Reduction in postprandial glucose excursion and prolongation of satiety: possible explanation of the long-term effects of whole grain Salba (Salvia Hispanica L.). Eur J Clin Nutr. 2010 Apr;64(4):436-8. doi: 10.1038/ejcn.2009.159. Epub 2010 Jan 20.</citation>
    <PMID>20087375</PMID>
  </results_reference>
  <results_reference>
    <citation>Ho H, Lee AS, Jovanovski E, Jenkins AL, Desouza R, Vuksan V. Effect of whole and ground Salba seeds (Salvia Hispanica L.) on postprandial glycemia in healthy volunteers: a randomized controlled, dose-response trial. Eur J Clin Nutr. 2013 Jul;67(7):786-8. doi: 10.1038/ejcn.2013.103. Epub 2013 Jun 19.</citation>
    <PMID>23778782</PMID>
  </results_reference>
  <results_reference>
    <citation>Guevara-Cruz M, Tovar AR, Aguilar-Salinas CA, Medina-Vera I, Gil-Zenteno L, Hernández-Viveros I, López-Romero P, Ordaz-Nava G, Canizales-Quinteros S, Guillen Pineda LE, Torres N. A dietary pattern including nopal, chia seed, soy protein, and oat reduces serum triglycerides and glucose intolerance in patients with metabolic syndrome. J Nutr. 2012 Jan;142(1):64-9. doi: 10.3945/jn.111.147447. Epub 2011 Nov 16.</citation>
    <PMID>22090467</PMID>
  </results_reference>
  <verification_date>June 2015</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>June 22, 2015</study_first_submitted>
  <study_first_submitted_qc>June 22, 2015</study_first_submitted_qc>
  <study_first_posted type="Estimate">June 24, 2015</study_first_posted>
  <last_update_submitted>June 25, 2015</last_update_submitted>
  <last_update_submitted_qc>June 25, 2015</last_update_submitted_qc>
  <last_update_posted type="Estimate">June 26, 2015</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>Instituto Mexicano del Seguro Social</investigator_affiliation>
    <investigator_full_name>Ana Elena Perez Verdin</investigator_full_name>
    <investigator_title>Dr.</investigator_title>
  </responsible_party>
  <keyword>Metabolic Syndrome X</keyword>
  <keyword>Chia</keyword>
  <keyword>Dyslipidemia</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Syndrome</mesh_term>
    <mesh_term>Metabolic Syndrome X</mesh_term>
  </condition_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

